Literature DB >> 29246956

Marshaling the Translational Potential of MC1R for Precision Risk Assessment of Melanoma.

Peter A Kanetsky1, Jennifer L Hay2.   

Abstract

Melanoma rates have been increasing in the United States, and neither primary (sun protection and avoidance) nor secondary (skin examination) prevention is practiced consistently, even by those with melanoma risk factors. Inherited variation at MC1R is a robust marker for increased risk of melanoma, even among individuals with "sun-resistant" phenotypes. Although MC1R conveys important information about inherited melanoma risk for a broad spectrum of individuals, concerns that MC1R feedback could have negative consequences, including increased distress about melanoma, inappropriate use of health services, and development of a false sense of security, are valid and require empirical examination. The time is right for high-quality research focusing on the translation of MC1R genotype into clinical and public health practice. If studies show MC1R genetic risk screening is effective at motivating behavior change, more melanomas may be detected at earliest stages for which surgical excision is highly curative or a large number of melanomas may be prevented altogether. While other genetic markers for melanoma susceptibility may emerge in the coming years, the burgeoning research agenda on the public health translational potential of MC1R genetic risk screening will inform and usefully advance current and future precision risk assessment of melanoma. Cancer Prev Res; 11(3); 121-4. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29246956      PMCID: PMC5839988          DOI: 10.1158/1940-6207.CAPR-17-0255

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  22 in total

1.  Melanoma knowledge, perception, and awareness in ethnic minorities in Chicago: recommendations regarding education.

Authors:  June K Robinson; Komal M Joshi; Sara Ortiz; Roopal V Kundu
Journal:  Psychooncology       Date:  2011-03       Impact factor: 3.894

2.  Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006.

Authors:  Hannah K Weir; Loraine D Marrett; Vilma Cokkinides; Jill Barnholtz-Sloan; Pragna Patel; Eric Tai; Ahmedin Jemal; Jun Li; Julian Kim; Donatus U Ekwueme
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

3.  Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study.

Authors:  Saskia C Sanderson; Suzanne C O'Neill; Della Brown White; Gerold Bepler; Lori Bastian; Isaac M Lipkus; Colleen M McBride
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

4.  MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.

Authors:  Maria Teresa Landi; Peter A Kanetsky; Shirley Tsang; Bert Gold; David Munroe; Timothy Rebbeck; Jennifer Swoyer; Monica Ter-Minassian; Mohammad Hedayati; Lawrence Grossman; Alisa M Goldstein; Donato Calista; Ruth M Pfeiffer
Journal:  J Natl Cancer Inst       Date:  2005-07-06       Impact factor: 13.506

5.  A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.

Authors:  Amelia K Smit; David Espinoza; Ainsley J Newson; Rachael L Morton; Georgina Fenton; Lucinda Freeman; Kate Dunlop; Phyllis N Butow; Matthew H Law; Michael G Kimlin; Louise A Keogh; Suzanne J Dobbinson; Judy Kirk; Peter A Kanetsky; Graham J Mann; Anne E Cust
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-10-04       Impact factor: 4.254

6.  Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.

Authors:  Dominique Scherer; Eduardo Nagore; Justo Lorenzo Bermejo; Adina Figl; Rafael Botella-Estrada; Ranjit Kumar Thirumaran; Sabrina Angelini; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

7.  Patients' understanding of and responses to multiplex genetic susceptibility test results.

Authors:  Kimberly A Kaphingst; Colleen M McBride; Christopher Wade; Sharon Hensley Alford; Robert Reid; Eric Larson; Andreas D Baxevanis; Lawrence C Brody
Journal:  Genet Med       Date:  2012-07       Impact factor: 8.822

8.  Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled Trial.

Authors:  Jennifer L Hay; Marianne Berwick; Kate Zielaskowski; Kirsten Am White; Vivian M Rodríguez; Erika Robers; Dolores D Guest; Andrew Sussman; Yvonne Talamantes; Matthew R Schwartz; Jennie Greb; Jessica Bigney; Kimberly A Kaphingst; Keith Hunley; David B Buller
Journal:  JMIR Res Protoc       Date:  2017-04-25

Review 9.  The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.

Authors:  Gareth J Hollands; David P French; Simon J Griffin; A Toby Prevost; Stephen Sutton; Sarah King; Theresa M Marteau
Journal:  BMJ       Date:  2016-03-15

10.  MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project.

Authors:  Elena Pasquali; José C García-Borrón; Maria Concetta Fargnoli; Sara Gandini; Patrick Maisonneuve; Vincenzo Bagnardi; Claudia Specchia; Fan Liu; Manfred Kayser; Tamar Nijsten; Eduardo Nagore; Rajiv Kumar; Johan Hansson; Peter A Kanetsky; Paola Ghiorzo; Tadeusz Debniak; Wojciech Branicki; Nelleke A Gruis; Jiali Han; Terry Dwyer; Leigh Blizzard; Maria Teresa Landi; Giuseppe Palmieri; Gloria Ribas; Alexander Stratigos; M Laurin Council; Philippe Autier; Julian Little; Julia Newton-Bishop; Francesco Sera; Sara Raimondi
Journal:  Int J Cancer       Date:  2014-06-18       Impact factor: 7.396

View more
  10 in total

1.  Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.

Authors:  Jennifer L Hay; Kate Zielaskowski; Kirsten Meyer White; Kimberly Kaphingst; Erika Robers; Dolores Guest; Andrew Sussman; Yvonne Talamantes; Matthew Schwartz; Vivian M Rodríguez; Yuelin Li; Elizabeth Schofield; Jessica Bigney; Keith Hunley; David Buller; Marianne Berwick
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

2.  Comprehension of skin cancer genetic risk feedback in primary care patients.

Authors:  Erva Khan; Kimberly A Kaphingst; Kirsten Meyer White; Andrew Sussman; Dolores Guest; Elizabeth Schofield; Yvonne T Dailey; Erika Robers; Matthew R Schwartz; Yuelin Li; David Buller; Keith Hunley; Marianne Berwick; Jennifer L Hay
Journal:  J Community Genet       Date:  2021-11-19

Review 3.  Germline mutations predisposing to melanoma.

Authors:  Atrin Toussi; Nicole Mans; Jeanna Welborn; Maija Kiuru
Journal:  J Cutan Pathol       Date:  2020-05-11       Impact factor: 1.587

4.  How Do Subjective Health Literacy Measures Work in Young Adults? Specifying "Online" or "Paper-Based" Forms Impacts Results.

Authors:  Mary C Politi; Courtney M Goodwin; Kimberly A Kaphingst; Xuechen Wang; Angela Fagerlin; Lindsay N Fuzzell; Sydney E Philpott-Streiff
Journal:  MDM Policy Pract       Date:  2020-05-27

5.  Genetic polymorphisms may influence the vertical growth rate of melanoma.

Authors:  Mariusz Sikora; Lidia Rudnicka; Barbara Borkowska; Agnieszka Kardynał; Monika Słowińska; Adriana Rakowska; Olga Warszawik-Hendzel; Anna Wiergowska; Iwona Ługowska; Piotr Rutkowski; Tadeusz Dębniak; Jan Lubiński; Małgorzata Olszewska
Journal:  J Cancer       Date:  2018-08-06       Impact factor: 4.207

6.  Behavioral and Psychological Outcomes Associated with Skin Cancer Genetic Testing in Albuquerque Primary Care.

Authors:  Jennifer L Hay; Kimberly A Kaphingst; David Buller; Elizabeth Schofield; Kirsten Meyer White; Andrew Sussman; Dolores Guest; Yvonne T Dailey; Erika Robers; Matthew R Schwartz; Yuelin Li; Keith Hunley; Marianne Berwick
Journal:  Cancers (Basel)       Date:  2021-08-12       Impact factor: 6.639

7.  Interest and Utility of MC1R Testing for Melanoma Risk in Dermatology Patients with a History of Nonmelanoma Skin Cancer.

Authors:  Jennifer L Hay; Erica H Lee; Stephanie N Christian; Elizabeth Schofield; Jada G Hamilton; Ciyu Yang; Bobak Hedayati; Keimya Sadeghi; Mark E Robson; Allan Halpern; Liying Zhang; Irene Orlow
Journal:  J Skin Cancer       Date:  2022-07-31

8.  Effects of health literacy skills, educational attainment, and level of melanoma risk on responses to personalized genomic testing.

Authors:  Kimberly A Kaphingst; Erva Khan; Kirsten Meyer White; Andrew Sussman; Dolores Guest; Elizabeth Schofield; Yvonne T Dailey; Erika Robers; Matthew R Schwartz; Yuelin Li; David Buller; Keith Hunley; Marianne Berwick; Jennifer L Hay
Journal:  Patient Educ Couns       Date:  2020-08-01

9.  Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies.

Authors:  Anne E Cust; Martin Drummond; Peter A Kanetsky; Alisa M Goldstein; Jennifer H Barrett; Stuart MacGregor; Matthew H Law; Mark M Iles; Minh Bui; John L Hopper; Myriam Brossard; Florence Demenais; John C Taylor; Clive Hoggart; Kevin M Brown; Maria Teresa Landi; Julia A Newton-Bishop; Graham J Mann; D Timothy Bishop
Journal:  J Invest Dermatol       Date:  2018-06-08       Impact factor: 8.551

10.  Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial.

Authors:  Amelia K Smit; Martin Allen; Brooke Beswick; Phyllis Butow; Hugh Dawkins; Suzanne J Dobbinson; Kate L Dunlop; David Espinoza; Georgina Fenton; Peter A Kanetsky; Louise Keogh; Michael G Kimlin; Judy Kirk; Matthew H Law; Serigne Lo; Cynthia Low; Graham J Mann; Gillian Reyes-Marcelino; Rachael L Morton; Ainsley J Newson; Jacqueline Savard; Lyndal Trevena; Sarah Wordsworth; Anne E Cust
Journal:  Genet Med       Date:  2021-08-12       Impact factor: 8.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.